{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:20:53Z","timestamp":1778754053496,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["U10EY018573"],"award-info":[{"award-number":["U10EY018573"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["K23 EY017897"],"award-info":[{"award-number":["K23 EY017897"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.ajo.2013.10.004","type":"journal-article","created":{"date-parts":[[2013,10,22]],"date-time":"2013-10-22T04:07:32Z","timestamp":1382414852000},"page":"318-326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["In\u00a0Vitro Susceptibility of Filamentous Fungal Isolates From\u00a0a Corneal Ulcer Clinical Trial"],"prefix":"10.1016","volume":"157","author":[{"given":"Prajna","family":"Lalitha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine Q.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. Venkatesh","family":"Prajna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajarathinam","family":"Karpagam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoharan","family":"Geetha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kieran S.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicky","family":"Cevallos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen D.","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha R.","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Lietman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajo.2013.10.004_bib1","first-page":"214","article-title":"Corneal blindness: a global perspective","volume":"79","author":"Whitcher","year":"2001","journal-title":"Bull World Health Organ"},{"issue":"11","key":"10.1016\/j.ajo.2013.10.004_bib2","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/bjo.81.11.965","article-title":"Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, South India","volume":"81","author":"Srinivasan","year":"1997","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2013.10.004_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00055735-200408000-00008","article-title":"Fungal keratitis","volume":"15","author":"Srinivasan","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2013.10.004_bib4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00003226-198706040-00002","article-title":"Selection of appropriate antifungal therapy","volume":"6","author":"O'Day","year":"1987","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.ajo.2013.10.004_bib5","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ajo.2003.11.078","article-title":"In\u00a0vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens","volume":"137","author":"Marangon","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2013.10.004_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archopht.125.6.789","article-title":"Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis","volume":"125","author":"Lalitha","year":"2007","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2013.10.004_bib7","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/ICO.0b013e31823f8ae0","article-title":"Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial","volume":"31","author":"Lalitha","year":"2012","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.ajo.2013.10.004_bib8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/ICO.0b013e318277ac74","article-title":"Fusarium keratitis: genotyping, in\u00a0vitro susceptibility and clinical outcomes","volume":"32","author":"Oechsler","year":"2013","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ajo.2013.10.004_bib9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.diagmicrobio.2008.07.003","article-title":"Determination of in\u00a0vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods","volume":"62","author":"Iqbal","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.ajo.2013.10.004_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1439-0507.2012.02194.x","article-title":"Epidemiology of Aspergillus keratitis at a tertiary care eye hospital in South India and antifungal susceptibilities of the causative agents","volume":"56","author":"Manikandan","year":"2013","journal-title":"Mycoses"},{"issue":"3","key":"10.1016\/j.ajo.2013.10.004_bib11","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/bjo.2009.158675","article-title":"Susceptibility testing and clinical outcome in fungal keratitis","volume":"94","author":"Shapiro","year":"2010","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2013.10.004_bib12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.4103\/0301-4738.86328","article-title":"Natamycin in the treatment of keratomycosis: correlation of treatment outcome and in\u00a0vitro susceptibility of fungal isolates","volume":"59","author":"Pradhan","year":"2011","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2013.10.004_bib13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/13693786.2011.584328","article-title":"Antifungal susceptibility of ocular fungal pathogens recovered from around the world against itraconazole, voriconazole, amphotericin B, and caspofungin","volume":"50","author":"Ozdemir","year":"2012","journal-title":"Med Mycol"},{"issue":"4","key":"10.1016\/j.ajo.2013.10.004_bib14","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/jamaophthalmol.2013.1497","article-title":"The Mycotic Ulcer Treatment Trial: a randomized trial comparing natamycin vs voriconazole","volume":"131","author":"Prajna","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2013.10.004_bib15","series-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. 2nd ed. Approved standard M38\u2013A2","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"issue":"6","key":"10.1016\/j.ajo.2013.10.004_bib16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/jop.2006.22.437","article-title":"Voriconazole and fungal keratitis: a report of two treatment failures","volume":"22","author":"Giaconi","year":"2006","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.ajo.2013.10.004_bib17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/myc.12062","article-title":"Fusarium keratitis in South India: causative agents, their antifungal susceptibilities and a rapid identification method for the Fusarium solani species complex","volume":"56","author":"Homa","year":"2013","journal-title":"Mycoses"},{"issue":"5","key":"10.1016\/j.ajo.2013.10.004_bib18","doi-asserted-by":"crossref","first-page":"E318","DOI":"10.1111\/j.1439-0507.2010.01913.x","article-title":"In\u00a0vitro susceptibility of filamentous fungi to itraconazole, voriconazole and posaconazole by Clinical and Laboratory Standards Institute reference method and E-test","volume":"54","author":"Kondori","year":"2011","journal-title":"Mycoses"},{"issue":"10","key":"10.1016\/j.ajo.2013.10.004_bib19","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1128\/JCM.00610-08","article-title":"In\u00a0vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species: comparison of commercially formulated natamycin eye drops to pharmaceutical-grade powder","volume":"46","author":"Lalitha","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.ajo.2013.10.004_bib20","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ajo.2008.06.008","article-title":"In\u00a0vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients","volume":"146","author":"Li","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2013.10.004_bib21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1442-9071.2009.02155.x","article-title":"Spectrum of fungal keratitis in central China","volume":"37","author":"Wang","year":"2009","journal-title":"Clin Experiment Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2013.10.004_bib22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10096-011-1323-x","article-title":"Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology","volume":"31","author":"Debourgogne","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.ajo.2013.10.004_bib23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/ICL.0b013e318235c5af","article-title":"Resistant Fusarium keratitis progressing to endophthalmitis","volume":"38","author":"Edelstein","year":"2012","journal-title":"Eye Contact Lens"},{"issue":"7","key":"10.1016\/j.ajo.2013.10.004_bib24","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/bjo.86.7.829-a","article-title":"Ocular and systemic posaconazole(SCH-56592) treatment of invasive Fusarium solani keratitis and endophthalmitis","volume":"86","author":"Sponsel","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2013.10.004_bib25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11046-012-9542-y","article-title":"Successful medical management of recalcitrant Fusarium solani keratitis: molecular identification and susceptibility patterns","volume":"174","author":"Taylan Sekeroglu","year":"2012","journal-title":"Mycopathologia"},{"issue":"2","key":"10.1016\/j.ajo.2013.10.004_bib26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ajo.2006.10.048","article-title":"Successful treatment of resistant ocular fusariosis with posaconazole (SCH-56592)","volume":"143","author":"Tu","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2013.10.004_bib27","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ajo.2008.04.019","article-title":"Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China","volume":"146","author":"Xie","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2013.10.004_bib28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/0301-4738.83614","article-title":"Molecular characterization of drug-resistant and drug-sensitive Aspergillus isolates causing infectious keratitis","volume":"59","author":"Nayak","year":"2011","journal-title":"Indian J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2013.10.004_bib29","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1136\/bjophthalmol-2012-301825","article-title":"Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial","volume":"96","author":"Prajna","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2013.10.004_bib30","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0002-9394(75)90730-8","article-title":"Principles in the management of oculomycosis. XXXI Edward Jackson memorial lecture","volume":"79","author":"Jones","year":"1975","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2013.10.004_bib31","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/archophthalmol.2010.102","article-title":"Comparison of natamycin and voriconazole for the treatment of fungal keratitis","volume":"128","author":"Prajna","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2013.10.004_bib32","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ophtha.2005.10.063","article-title":"Risk factors for treatment outcome in fungal keratitis","volume":"113","author":"Lalitha","year":"2006","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2013.10.004_bib33","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/bjo.82.8.919","article-title":"Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh","volume":"82","author":"Rahman","year":"1998","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2013.10.004_bib34","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/jac\/42.6.741","article-title":"In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi","volume":"42","author":"Johnson","year":"1998","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.ajo.2013.10.004_bib35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12281-009-0017-7","article-title":"Updates in antifungal susceptibility testing of filamentous fungi","volume":"3","author":"Espinel-Ingroff","year":"2009","journal-title":"Curr Fungal Infect Rep"},{"key":"10.1016\/j.ajo.2013.10.004_bib36","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Voriconazole: rationale for the clinical breakpoints, version 1.0, 2012. Available at http:\/\/www.eucast.org. Accessed May 4, 2013."},{"issue":"6","key":"10.1016\/j.ajo.2013.10.004_bib37","doi-asserted-by":"crossref","first-page":"E278","DOI":"10.1111\/1469-0691.12148","article-title":"EUCAST Technical note on voriconazole and Aspergillus spp","volume":"19","author":"Hope","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1016\/j.ajo.2013.10.004_bib38","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1128\/JCM.00536-10","article-title":"Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)","volume":"48","author":"Espinel-Ingroff","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.ajo.2013.10.004_bib39","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1128\/JCM.00940-09","article-title":"Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods","volume":"47","author":"Pfaller","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.ajo.2013.10.004_bib40","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.00156-08","article-title":"Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus","volume":"52","author":"Rodriguez-Tudela","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.ajo.2013.10.004_bib41","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/JCM.02136-10","article-title":"Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Aspergillus species to the triazoles","volume":"49","author":"Pfaller","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.ajo.2013.10.004_bib42","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1128\/JCM.00535-08","article-title":"In\u00a0vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.ajo.2013.10.004_bib43","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1086\/342384","article-title":"Has antifungal susceptibility testing come of age?","volume":"35","author":"Rex","year":"2002","journal-title":"Clin Infect Dis"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939413006855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939413006855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:39:58Z","timestamp":1762079998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939413006855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0002939413006855"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2013.10.004","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In\u00a0Vitro Susceptibility of Filamentous Fungal Isolates From\u00a0a Corneal Ulcer Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2013.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}